Login

VC Firm investing in the lifesciences|Daniel Yadegar,Chief Medical Officer,Newpath Partners 00:10:00

Share On Facebook Share On Twitter

Daniel Yadegar is the Co-Founder and CMO of Newpath Management.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Unlocking the future of radio systems testing: David Adams of PCTEL provides insights alongside Gamma Electronics Inc. in an owner review.
00:10:00
"IoT Talks 2023 features Kjell Johnsen, CEO of Tele2."|Kjell Morten Johnsen is the CEO of Tele2
00:10:00
Cardo Tours Canada Partners with Alto Helix for East Coast Edition
00:10:00
Help when it comes to selecting the best software based on the unique factors of the business|Alex Bass,General Partner, Efficient VC
00:10:00
CTP CEO Remon Vos Highlights Strong Q1 2023 Results | Remon Vos, President, CTP NV.
00:10:00
The EDV is proving safe and effective across a number of late-stage, intractable cancers like pancreatic cancer and mesothelioma| Dr Jennifer MacDiarmid , CEO OF ENGENEIC
00:10:00
CICT’s Forward-Thinking Strategies for Resilient Growth and Sustainable Operations|Tony Tan Tee Hieong,CEO,CapitaLand Integrated Commercial Trust
00:10:00
Odyssey Marine Exploration: Sustainable Marine Mining for Critical Minerals
00:10:00
Sanko Gold: Driving Growth and Cash Flow from Ghana's Assanko Mine
00:10:00
An interview with Aferian plc CEO Donald McGarva | Donald McGarva, CEO, Aferian PLCAFRN:LSE
00:10:00
Freestyle boasts a portfolio of 130 plus companies|Dave Samuel,Founding General Partner,Freestyle Capital
00:10:00
Alan Knuckman from TheMorningTrade highlights the potential upside he sees in Weibo Corp. (#WB).

© 2017 - Neuhu+